- Medicus Pharma (TSXV:MDCX:CA) priced its US initial public offering of 970,000 units at a price of $4.125 per unit.
- Medicus Pharma (MDCX:CA) is a biotechnology and life sciences company focused on accelerating clinical development programs for novel and disruptive therapeutic assets.
- Each